| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antibody–Drug Conjugates in Thoracic Malignancies: Clinical Trials Reveal Both Promise and Challenges
|
Payan, Sandrine
|
|
|
15 |
4 |
p. 429-448
|
article
|
| 2 |
Biologic Drug Quality Assurance to OptimizeHER2 + Breast Cancer Treatment: Insights from Development of the Trastuzumab BiosimilarSB3
|
Lüftner, Diana
|
|
|
15 |
4 |
p. 467-475
|
article
|
| 3 |
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis
|
Iacovelli, Roberto
|
|
|
15 |
4 |
p. 495-501
|
article
|
| 4 |
Ceritinib-Induced Organizing Pneumonia in Lung Cancer: A Retrospective Analysis
|
Choi, Wonyoung
|
|
|
15 |
4 |
p. 513-522
|
article
|
| 5 |
Clinical Relevance of BRAF V600E Mutation Status in Brain Tumors with a Focus on a Novel Management Algorithm
|
Kowalewski, Adam
|
|
|
15 |
4 |
p. 531-540
|
article
|
| 6 |
Comparison of Large, Medium, and Small Solid Tumor Gene Panels for Detection of Clinically Actionable Mutations in Cancer
|
Vail, Eric
|
|
|
15 |
4 |
p. 523-530
|
article
|
| 7 |
Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and Prednisone
|
Sheng, Iris Y.
|
|
|
15 |
4 |
p. 477-483
|
article
|
| 8 |
Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
|
Michel, Laura L.
|
|
|
15 |
4 |
p. 415-428
|
article
|
| 9 |
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
|
Raschi, Emanuel
|
|
|
15 |
4 |
p. 449-466
|
article
|
| 10 |
Management of Adverse Events Associated with Cabozantinib Treatment in Patients with Advanced Hepatocellular Carcinoma
|
Schwartz, Gabriel
|
|
|
15 |
4 |
p. 549-565
|
article
|
| 11 |
Post-Progression Survival in Secondary EGFR T790M-Mutated Non-Small-Cell Lung Cancer Patients With and Without Osimertinib After Failure of a Previous EGFR TKI
|
Chiang, Chi-Lu
|
|
|
15 |
4 |
p. 503-512
|
article
|
| 12 |
Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study
|
Oh, Chung Ryul
|
|
|
15 |
4 |
p. 485-493
|
article
|
| 13 |
Untangling the Multidisciplinary Care Web: Streamlining Care Through an Immune-Related Adverse Events (IRAE) Tumor Board
|
Kennedy, Laura C.
|
|
|
15 |
4 |
p. 541-548
|
article
|
Journal description